AN ANTI-MICA/B MONOCLONAL ANTIBODY SUPPORTS ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY TO INTRAHEPATIC CHOLANGIOCARCINOMA CELLS.